• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于选择一组最小的体外检测方法来可靠地确定雌激素激动剂活性。

On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.

机构信息

U.S. Environmental Protection Agency, RTP, NC, United States.

U.S. Environmental Protection Agency, RTP, NC, United States.

出版信息

Regul Toxicol Pharmacol. 2017 Dec;91:39-49. doi: 10.1016/j.yrtph.2017.09.022. Epub 2017 Oct 6.

DOI:10.1016/j.yrtph.2017.09.022
PMID:28993267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5796525/
Abstract

The US EPA is charged with screening chemicals for their ability to be endocrine disruptors through interaction with the estrogen, androgen and thyroid axes. The agency is exploring the use of high-throughput in vitro assays to use in the Endocrine Disruptor Screening Program (EDSP), potentially as replacements for lower-throughput in vitro and in vivo tests. The first replacement is an integrated computational and experimental model for estrogen receptor (ER) activity, to be used as an alternative to the EDSP Tier 1 in vitro ER binding and transactivation assays and the in vivo uterotrophic bioassay. The ER agonist model uses a set of 16 in vitro assays that incorporate multiple technologies and cell lines and probe multiple points in the ER pathway. Here, we demonstrate that subsets of assays with as few as 4 assays can predict the activity of all 1811 chemicals tested with accuracy equivalent to that of the full 16-assay model. The prediction accuracy against reference chemicals is higher than that of the full chemical set, partly because the larger set contains many chemicals that can cause a variety of types of assay interference There are multiple accurate assay subsets, allowing flexibility in the construction of a multiplexed assay battery. We also discuss the issue of challenging chemicals, i.e. those that can give false positive results in certain assays, and could hence be more problematic when only a few assays are used.

摘要

美国环保署负责通过与雌激素、雄激素和甲状腺轴的相互作用,筛选具有内分泌干扰潜力的化学物质。该机构正在探索使用高通量体外检测方法来应用于内分泌干扰物筛选计划(EDSP),这些方法可能替代低通量的体外和体内测试。第一个替代品是雌激素受体(ER)活性的综合计算和实验模型,可作为 EDSP 第 1 层体外 ER 结合和转激活检测以及体内子宫增重生物检测的替代方法。ER 激动剂模型使用了一组 16 种体外检测方法,这些方法结合了多种技术和细胞系,并探测了 ER 途径中的多个点。在这里,我们证明了具有多达 4 种检测方法的子集中,可以准确预测所有 1811 种经过测试的化学物质的活性,其准确性与完整的 16 种检测方法模型相当。与参考化学物质相比,该预测方法的准确性更高,部分原因是较大的集合包含许多可能引起各种类型检测干扰的化学物质。有多个准确的检测子集,可以灵活构建多重检测电池。我们还讨论了具有挑战性的化学物质的问题,即那些在某些检测中可能产生假阳性结果的化学物质,因此当只使用少数检测方法时,这些化学物质可能会更成问题。

相似文献

1
On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.关于选择一组最小的体外检测方法来可靠地确定雌激素激动剂活性。
Regul Toxicol Pharmacol. 2017 Dec;91:39-49. doi: 10.1016/j.yrtph.2017.09.022. Epub 2017 Oct 6.
2
Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.美国环境保护局内分泌干扰物筛选计划(EDSP)一级体外试验执行情况的关键经验教训。
Birth Defects Res B Dev Reprod Toxicol. 2014 Feb;101(1):23-42. doi: 10.1002/bdrb.21094. Epub 2014 Feb 10.
3
Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.采用体外高通量筛选检测方法来鉴定潜在的内分泌干扰化学物。
Environ Health Perspect. 2013 Jan;121(1):7-14. doi: 10.1289/ehp.1205065. Epub 2012 Sep 28.
4
Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.采用 QSAR 和基于结构的虚拟筛选方法鉴定潜在的雌激素受体介导的内分泌干扰化学物质。
Toxicol Appl Pharmacol. 2013 Oct 1;272(1):67-76. doi: 10.1016/j.taap.2013.04.032. Epub 2013 May 23.
5
Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.利用计算模型筛选具有雌激素受体生物活性的化学物质。
Environ Sci Technol. 2015 Jul 21;49(14):8804-14. doi: 10.1021/acs.est.5b02641. Epub 2015 Jun 26.
6
Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.针对现有基于雌激素受体高通量分析的活性模型进行化学适用性评估。
Front Toxicol. 2024 Apr 17;6:1346767. doi: 10.3389/ftox.2024.1346767. eCollection 2024.
7
Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.使用18种雌激素受体体外高通量筛选检测方法对生物途径化学扰动进行的综合模型
Toxicol Sci. 2015 Nov;148(1):137-54. doi: 10.1093/toxsci/kfv168. Epub 2015 Aug 13.
8
Assessing utility of thyroid in vitro screening assays through comparisons to observed impacts in vivo.通过与体内观察到的影响进行比较来评估甲状腺体外筛选检测的效用。
Regul Toxicol Pharmacol. 2023 Oct;144:105491. doi: 10.1016/j.yrtph.2023.105491. Epub 2023 Sep 4.
9
Towards replacement of animal tests with in vitro assays: a gene expression biomarker predicts in vitro and in vivo estrogen receptor activity.迈向用体外试验替代动物试验:一种基因表达生物标志物可预测体外和体内雌激素受体活性。
Chem Biol Interact. 2022 Aug 25;363:109995. doi: 10.1016/j.cbi.2022.109995. Epub 2022 Jun 11.
10
Performance of the BG1Luc ER TA method in a qHTS format.BG1Luc ER TA方法在定量高通量筛选(qHTS)模式下的性能。
ALTEX. 2015;32(4):287-96. doi: 10.14573/altex.1505121. Epub 2015 Jun 28.

引用本文的文献

1
Estrogenic activity of mixtures in the Salish Sea: The use of high throughput toxicity data with chemical information from fish bile and other matrices.萨利希海混合物的雌激素活性:利用高通量毒性数据及来自鱼胆汁和其他基质的化学信息
PLoS One. 2025 Jul 9;20(7):epone.0323865. doi: 10.1371/journal.pone.0323865. eCollection 2025.
2
Screening for Endocrine Bioactivity Potential of Tobacco Product Chemicals Including Flavor Chemicals.烟草制品化学物质(包括香料化学物质)内分泌生物活性潜力的筛查
Environ Toxicol. 2025 Jun;40(6):935-945. doi: 10.1002/tox.24472. Epub 2025 Jan 30.
3
Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.针对现有基于雌激素受体高通量分析的活性模型进行化学适用性评估。
Front Toxicol. 2024 Apr 17;6:1346767. doi: 10.3389/ftox.2024.1346767. eCollection 2024.
4
Optimizing androgen receptor prioritization using high-throughput assay-based activity models.使用基于高通量检测的活性模型优化雄激素受体优先级排序。
Front Toxicol. 2024 Mar 11;6:1347364. doi: 10.3389/ftox.2024.1347364. eCollection 2024.
5
A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals.一种用于测试内分泌干扰化学物质的新型雌激素受体β高通量显微镜平台。
Heliyon. 2023 Dec 8;10(1):e23119. doi: 10.1016/j.heliyon.2023.e23119. eCollection 2024 Jan 15.
6
Exploring the effects of experimental parameters and data modeling approaches on in vitro transcriptomic point-of-departure estimates.探讨实验参数和数据建模方法对体外转录组起点估计的影响。
Toxicology. 2024 Jan;501:153694. doi: 10.1016/j.tox.2023.153694. Epub 2023 Dec 2.
7
High-throughput AR dimerization assay identifies androgen disrupting chemicals and metabolites.高通量雄激素受体二聚化检测可识别雄激素干扰化学物质和代谢物。
Front Toxicol. 2023 Apr 4;5:1134783. doi: 10.3389/ftox.2023.1134783. eCollection 2023.
8
A tiered testing strategy based on in vitro phenotypic and transcriptomic data for selecting representative petroleum UVCBs for toxicity evaluation in vivo.基于体外表型和转录组数据的分层测试策略,用于选择具有代表性的石油 UVCB 进行体内毒性评估。
Toxicol Sci. 2023 May 31;193(2):219-233. doi: 10.1093/toxsci/kfad041.
9
Vanillin-Based Indolin-2-one Derivative Bearing a Pyridyl Moiety as a Promising Anti-Breast Cancer Agent via Anti-Estrogenic Activity.基于香草醛的含吡啶基吲哚-2-酮衍生物作为一种有前景的抗乳腺癌药物通过抗雌激素活性发挥作用。
ACS Omega. 2023 Feb 8;8(7):6968-6981. doi: 10.1021/acsomega.2c07793. eCollection 2023 Feb 21.
10
New Approach Methodologies for the Endocrine Activity Toolbox: Environmental Assessment for Fish and Amphibians.内分泌活性工具箱的新方法学:鱼类和两栖类的环境评估。
Environ Toxicol Chem. 2023 Apr;42(4):757-777. doi: 10.1002/etc.5584. Epub 2023 Mar 20.

本文引用的文献

1
Editor's Highlight: Analysis of the Effects of Cell Stress and Cytotoxicity on In Vitro Assay Activity Across a Diverse Chemical and Assay Space.编辑推荐:在不同化学物质和检测体系中分析细胞应激和细胞毒性对体外检测活性的影响
Toxicol Sci. 2016 Aug;152(2):323-39. doi: 10.1093/toxsci/kfw092. Epub 2016 May 20.
2
A Curated Database of Rodent Uterotrophic Bioactivity.一个精心整理的啮齿动物子宫营养生物活性数据库。
Environ Health Perspect. 2016 May;124(5):556-62. doi: 10.1289/ehp.1510183. Epub 2015 Oct 2.
3
Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.使用18种雌激素受体体外高通量筛选检测方法对生物途径化学扰动进行的综合模型
Toxicol Sci. 2015 Nov;148(1):137-54. doi: 10.1093/toxsci/kfv168. Epub 2015 Aug 13.
4
Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.开发一种含有雌激素受体α和β的重组人卵巢(BG1)细胞系,用于改进对雌激素/抗雌激素化学物质的检测。
Environ Toxicol Chem. 2016 Jan;35(1):91-100. doi: 10.1002/etc.3146. Epub 2015 Dec 9.
5
Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.利用计算模型筛选具有雌激素受体生物活性的化学物质。
Environ Sci Technol. 2015 Jul 21;49(14):8804-14. doi: 10.1021/acs.est.5b02641. Epub 2015 Jun 26.
6
Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.支持 21 世纪毒理学测试的高通量检测方法验证的观点。
ALTEX. 2013;30(1):51-6. doi: 10.14573/altex.2013.1.051.
7
Rules for identifying potentially reactive or promiscuous compounds.潜在反应性或混杂化合物的鉴定规则。
J Med Chem. 2012 Nov 26;55(22):9763-72. doi: 10.1021/jm301008n. Epub 2012 Oct 25.
8
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.新型亚结构筛选器,可用于从筛选库中去除泛分析干扰化合物(PAINS),并在生物测定中对其进行排除。
J Med Chem. 2010 Apr 8;53(7):2719-40. doi: 10.1021/jm901137j.
9
A modular approach to the ECVAM principles on test validity.一种基于欧洲替代方法验证中心(ECVAM)测试有效性原则的模块化方法。
Altern Lab Anim. 2004 Nov;32(5):467-72. doi: 10.1177/026119290403200503.
10
Environmental and dietary estrogens and human health: is there a problem?环境与膳食中的雌激素与人类健康:存在问题吗?
Environ Health Perspect. 1995 Apr;103(4):346-51. doi: 10.1289/ehp.95103346.